ISSN 1473-5741 - Anti-cancer drugs (Online)

This resource has been partly archived by the keepers network.

Archival Status
Publisher	Keeper	Status	Last updated
on 1
Wolters Kluwer Health	Portico	Preserved	2026-04-30
Preserved : 1990: 1(1-2), 1991: 2(1-6), 1992: 3(1, S 1, 2-6), 1993: 4(1, S 1, 2, S 2, 3-6), 1994: 5(1, S 1, 2-6), 1995: 6(1, S 1, 2, S 2, 3-4, S 4, 5, S 5, 6, S 6), 1996: 7(1, S 1, 2, S 2, S 2 2, 3-8), 1997: 8(1-2, S 2, 3-10), 1998: 9(1-10), 1999: 10(1, S 1, 2-10), 2000: 11(1-10), 2001: 12(1-10), 2002: 13(1-5, S 5, 6-10), 2003: 14(1-6), 2004: 15(1-10), 2005: 16(1-10), 2006: 17(1-10), 2007: 18(1-10), 2008: 19(1, S 1, 2, S 2, 3-10), 2009: 20(1, Special Issue 1, 2, Special Issue 2, 3, Special Issue 3, 4-10), 2010: 21(1, S 1, 2-10), 2011: 22(1, S 1, 2-10, Bevacizumab in the treatment of metastatic colorectal cancer: Case reports), 2012: 23(1-10, Imatinib in gastrointestinal stromal tumour(GIST) therapy), 2013: 24(1-10), 2014: 25(1-10, Update on Taxanes in Cancer Therapy), 2015: 26(1-10), 2016: 27(1-10), 2017: 28(1-10), 2018: 29(1-10), 2019: 30(1-10), 2020: 31(1-10), 2021: 32(1-10), 2022: 33(1-10), 2023: 34(1-10), 2024: 35(1-10), 2025: 36(1-10), 2026: 37(1-5)
Wolters Kluwer Health	CLOCKSS Archive	Preserved	2026-04-27
Publish, Ahead, o, 23 to 37

3:: Vol. 34, issue 1 (January 2023) (journals.lww.com website, viewed January 26, 2023).

ISSN Record 1473-5741